Clinical Research Directory
Browse clinical research sites, groups, and studies.
MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study
Sponsor: Mayo Clinic
Summary
This study is being done to screen adults for MGUS and to better understand the genetic and immune factors linked to this condition. Monoclonal gammopathy of undetermined significance or MGUS is a condition where an abnormal immune protein is found in the blood. MGUS is not cancer. In some people, it slowly develops into a blood cancer called multiple myeloma. MGUS occurs in people from all backgrounds. Researchers hope to use the information from this study to improve knowledge, early detection, and future care for everyone.
Official title: Monoclonal Gammopathy of Undetermined Significance (MGUS) /Myeloma Awareness and Genetic Insights Campaign (MAGIC) Screening Study
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
OBSERVATIONAL
Enrollment
1000
Start Date
2024-05-22
Completion Date
2029-05-31
Last Updated
2026-03-30
Healthy Volunteers
Yes
Interventions
Non-Interventional Study
Non-interventional study
Locations (1)
Mayo Clinic in Rochester
Rochester, Minnesota, United States